Chevron vs. Exxon: Which is the Better Investment After Strong Q1 Results?
With crude prices hovering above $100 per barrel, investors may be wondering which oil giant is the…

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Trend
-7.2% vs SMA 50 · -15.4% vs SMA 200
Momentum
Distribution pattern detected. More selling days than accumulation over the past 20 sessions. Not a conducive environment for a squeeze.
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2025 | $1.3B $1.3B–$1.3B | — | $0.66 | — | ±1% | High8 |
FY2026(current) | $1.4B $1.4B–$1.4B | ▲ +7.6% | $1.17 | ▲ +77.4% | ±1% | High7 |
FY2027 | $1.5B $1.5B–$1.5B | ▲ +9.7% | $1.36 | ▲ +16.8% | ±5% | High8 |
With crude prices hovering above $100 per barrel, investors may be wondering which oil giant is the…

Progyny is a leading fertility benefits management company in the US. The company is redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians.
| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
PGNY◀ | $18.91 | +0.11% | $1.5B | 27.1 | +1040.4% | 454.1% | 1500 |
| $68.99 | -3.59% | $13.3B | — | +12626.1% | -14525.8% | 1500 | |
| $518.66 | -0.71% | $11.8B | — | +43205.3% | -3008.0% | 1500 | |
| $91.17 | +0.60% | $11.5B | — | +3288.2% | -4239.0% | 1500 | |
| $182.03 | -1.59% | $10.7B | 29.2 | +1871.5% | 680.1% | 1500 | |
| $223.70 | -0.59% | $10.6B | — | +6554.5% | -2868.8% | 1500 | |
| $76.39 | +1.81% | $10.5B | 51.8 | +2325815.3% | -19.7% | 1500 | |
| Sector avg | — | -0.57% | — | 36.0 | +342057.3% | -3361.0% | 1500 |